TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Integrativ Biomedicin Öckerman AB
Closing information (x1000 DKK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
274
|
341 | |
| Financial expenses |
0
|
1 | |
| Earnings before taxes |
103
|
147 | |
| EBITDA |
38
|
81 | |
| Total assets |
410
|
494 | |
| Current assets |
394
|
478 | |
| Current liabilities |
19
|
28 | |
| Equity capital |
377
|
453 | |
| - share capital |
65
|
67 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
92.0%
|
91.7% | |
| Turnover per employee |
274
|
341 | |
| Profit as a percentage of turnover |
37.6%
|
43.1% | |
| Return on assets (ROA) |
25.1%
|
30.0% | |
| Current ratio |
2073.7%
|
1707.1% | |
| Return on equity (ROE) |
27.3%
|
32.5% | |
| Change turnover |
-55
|
28 | |
| Change turnover % |
-61%
|
-17%
|
9% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.